Predicting Surgical Defect Size for Rare Eye Cancers

A new model helps surgeons predict tissue loss for patients with periocular basosquamous carcinoma before surgery.

Updated on Oct. 30, 2026 in Cancer

Isometric editorial illustration showing a medical caliper next to cubic geometric shapes, representing surgical tissue measurement and predictive modeling.
Researchers in Dallas developed a predictive model using linear regression to estimate tissue loss for patients undergoing surgery for periocular basosquamous carcinoma. AI Illustration. Upload story photo >

A new retrospective study shows that preoperative lesion area can predict the final defect size after Mohs surgery for periocular basosquamous carcinoma. This predictive modeling may assist surgeons in Dallas with preoperative planning for this complex skin cancer.

Why it matters

Basosquamous carcinoma of the eyelid is known to be more aggressive and prone to wider margins than other common skin cancers. Having a reliable way to estimate the final surgical defect allows both patients and surgeons to better prepare for the reconstructive process.

This retrospective study analyzed 11 basosquamous, 69 basal cell, and 25 squamous cell carcinoma cases treated between 2010 and 2025. Researchers found that preoperative measurements successfully predicted final defect size with an R-squared value of 0.91.

The players

UT Southwestern Medical Center

An academic medical institution where researchers conducted the analysis of surgical outcomes.

The details

Researchers utilized ImageJ software to measure preoperative lesion areas and then applied linear regression analysis to estimate the final dimensions of the surgical wound. By identifying a correlation between the initial size of the lesion and the resulting defect, surgeons can anticipate the amount of tissue loss expected after removing the tumor. This mathematical approach helps quantify the aggressive growth patterns typical of basosquamous carcinoma compared to more common skin cancers.

Timeline

  1. Data for this study were collected from cases treated between 2010 and 2025.

  2. Findings were presented at academic meetings held from October 8-12, 2026.

Health Landscape

Mohs surgery remains the gold standard for removing periocular skin cancers while preserving healthy tissue. This research enhances the clinical standard of care by providing a mathematical framework to better predict tissue loss for rare, aggressive cancers.

If you have been diagnosed with a periocular skin lesion, it is worth asking your surgeon if they utilize preoperative mapping to estimate tissue loss. Understanding the potential size of a surgical defect can help you prepare for the reconstruction and recovery process.

The takeaway

Basosquamous carcinoma can be more aggressive than other skin cancers, leading to larger surgical wounds than typically expected. Talk with your dermatologist or Mohs surgeon about the expected extent of any planned excision to help you set realistic expectations for your procedure.

Further reading

To learn more about how specialists approach skin cancer treatment, visit the Cancer section.

Source note: This article includes information reported by Cancer Therapy Advisor.